Transcriptional networks underlying tumour plasticity in small-cell lung cancer

Abstract

Across human malignancies, the ability of cancer cells to switch states (plasticity) drives progression, metastasis, and therapy resistance 1-3. Here we investigated the transcriptional and epigenetic basis of plasticity in small-cell lung cancer (SCLC), an aggressive, treatment-refractory cancer 4, 5. SCLC tumours display plasticity along a neuroendocrine (NE) to nonNE axis; however, the trajectories of lineage transition and the gene regulatory network underlying it, remain poorly defined 6. Using single-cell multi-omics, we resolved distinct transcriptional SCLC cell states, including a previously unrecognised Intermediate state comprised of low-identity immunogenic SCLC cells that serve as an obligatory route in NE to nonNE lineage transition. Using single-cell gene expression and chromatin accessibility data, we next developed a Boolean Bayes model for transcription factor networks (BoBa-T) to predict regulators of SCLC cell states. We validated RORB as a novel gatekeeper of the NE state that represses the nonNE identity in SCLC. RORB inactivation drives NE cells into the Intermediate state, upregulates immunogenic programs, and inhibits tumour growth in immunocompetent hosts. Our work identifies a plastic, immunogenic waypoint for SCLC lineage switching and reveals strategies to target it therapeutically.

Plasticity and immune marker profiling of tumour- and ascites-derived microtumours in serous ovarian cancer: relevance for short-term culture models
Louisa Hell, Yi Ding, Clara Pellens +9
Frontiers in Immunology7 Oct 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMC
The Molecular Landscape of the Senescence-EMT Interplay: Deciphering Tumour Plasticity Through Molecular Signatures and Multi-Omic Profiling.
Eva M Verdugo-Sivianes, Carmen Campos-Silva, José Luis García-Márquez +1
Cancers4 Oct 2026Peer-reviewedCC BYFull textPhysiologyEurope PMCCrossref
Host transcriptional programs underlying lesion development in contagious bovine pleuropneumonia
Arlind B. Mara, Angela Makumi, Rosemary Grace Ozyck +11
Frontiers in Immunology30 Oct 2026Peer-reviewedCC BY 4.0Full textImmunology General medicineCrossrefDOAJ
Epithelial–mesenchymal plasticity is associated with transcriptional variation in regulated cell death and immune signaling programs in lung adenocarcinoma
Kuiyuan Liu, Jia Liu, Tiebao Meng +2
Frontiers in cell and developmental biology20 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCPMC
ReCAST: Single-Cell-Informed Tumour Microenvironment Profiling for Translational Prognostic Assessment in Esophageal Cancer
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@misc{bhattacharya2026transcriptional,
  title = {{Transcriptional networks underlying tumour plasticity in small-cell lung cancer}},
  author = {D. Bhattacharya and S. M. Groves and C. Walker and G. N. Duorino and M. Hsieh and Y. Chtourou and G. G. Hartmann and W.-H. Hsu and C. Liu and M. Angelo and V. Quaranta and J. Sage},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.26.754526},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.26.754526v1},
  note = {CC BY},
}

RIS

TY  - UNPB
TI  - Transcriptional networks underlying tumour plasticity in small-cell lung cancer
AU  - D. Bhattacharya
AU  - S. M. Groves
AU  - C. Walker
AU  - G. N. Duorino
AU  - M. Hsieh
AU  - Y. Chtourou
AU  - G. G. Hartmann
AU  - W.-H. Hsu
AU  - C. Liu
AU  - M. Angelo
AU  - V. Quaranta
AU  - J. Sage
PY  - 2026
DA  - 2026/09/26
PB  - bioRxiv
DO  - 10.64898/2026.09.26.754526
UR  - https://www.biorxiv.org/content/10.64898/2026.09.26.754526v1
AB  - Across human malignancies, the ability of cancer cells to switch states (plasticity) drives progression, metastasis, and therapy resistance 1-3. Here we investigated the transcriptional and epigenetic basis of plasticity in small-cell lung cancer (SCLC), an aggressive, treatment-refractory cancer 4, 5. SCLC tumours display plasticity along a neuroendocrine (NE) to nonNE axis; however, the trajectories of lineage transition and the gene regulatory network underlying it, remain poorly defined 6. Using single-cell multi-omics, we resolved distinct transcriptional SCLC cell states, including a previously unrecognised Intermediate state comprised of low-identity immunogenic SCLC cells that serve as an obligatory route in NE to nonNE lineage transition. Using single-cell gene expression and chromatin accessibility data, we next developed a Boolean Bayes model for transcription factor networks (BoBa-T) to predict regulators of SCLC cell states. We validated RORB as a novel gatekeeper of the NE state that represses the nonNE identity in SCLC. RORB inactivation drives NE cells into the Intermediate state, upregulates immunogenic programs, and inhibits tumour growth in immunocompetent hosts. Our work identifies a plastic, immunogenic waypoint for SCLC lineage switching and reveals strategies to target it therapeutically.
ER  -

Abstract

Related

Cite